2022
DOI: 10.1093/eurjpc/zwac211
|View full text |Cite
|
Sign up to set email alerts
|

Randomized trial of cardiovascular prevention in Norway combining an in-hospital lifestyle course with primary care follow-up: the Hjerteløftet study

Abstract: Background Cardiovascular risk factor control is suboptimal in Europe, including Norway. The present study examined the efficacy of a multimodal primary prevention intervention program based on the existing Norwegian health care system. Methods In this open-label randomized controlled trial, adult patients with elevated cardiovascular risk were randomly assigned to an intervention program including a hospital-based lifestyle … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…A major finding in the present substudy of a primary prevention trial [ 2 ], was a statistically significant increased PA level in favour of the IG. The program also resulted in a within group significant decrease in the proportion of patients reporting being inactive in the IG, while the decrease was less prominent in the CG.…”
Section: Discussionmentioning
confidence: 71%
See 4 more Smart Citations
“…A major finding in the present substudy of a primary prevention trial [ 2 ], was a statistically significant increased PA level in favour of the IG. The program also resulted in a within group significant decrease in the proportion of patients reporting being inactive in the IG, while the decrease was less prominent in the CG.…”
Section: Discussionmentioning
confidence: 71%
“…As described in detail previously [ 2 ], patients in the Hjerteløftet Study were referred for participation from general practitioners (GP) in Norway and could be included if 35—67 years of age and had elevated CVD risk. Elevated risk was defined as being at least 50% of the risk-threshold where pharmacological intervention was recommended according to national clinical guidelines [ 10 ].…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations